{"id":956,"date":"2006-04-01T12:02:00","date_gmt":"2006-04-01T10:02:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2006\/hirsutismus"},"modified":"2006-04-01T12:02:00","modified_gmt":"2006-04-01T10:02:00","slug":"hirsutismus","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2006\/hirsutismus","title":{"rendered":"Hirsutismus"},"content":{"rendered":"<p>Zusammenfassung: Zur Therapie des leichten Hirsutismus, der von einer Hypertrichose unterschieden werden muss, gen\u00fcgen oft kosmetisch-dermatologische Behandlungsmethoden. Orale Kontrazeptiva ohne oder mit antiandrogenem Gestagen sind in den meisten F\u00e4llen die Therapie der Wahl. Bei h\u00f6hergradigem Hirsutismus m\u00fcssen oft Antiandrogene (immer kombiniert mit sicherer Kontrazeption, meist oralen Kontrazeptiva) angewendet werden. Diese Therapie sollte von erfahrenen Frauen\u00e4rzt(inn)en [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zusammenfassung: Zur Therapie des leichten Hirsutismus, der von einer Hypertrichose unterschieden werden muss, gen\u00fcgen oft kosmetisch-dermatologische Behandlungsmethoden. Orale Kontrazeptiva ohne oder mit antiandrogenem Gestagen sind in den meisten F\u00e4llen die Therapie der Wahl. Bei h\u00f6hergradigem Hirsutismus m\u00fcssen oft Antiandrogene (immer kombiniert mit sicherer Kontrazeption, meist oralen Kontrazeptiva) angewendet werden. Diese Therapie sollte von erfahrenen Frauen\u00e4rzt(inn)en [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1320,1319,2437,2435,273,272,281,282,822,2434,57,2436,2438,2440,1392,2441,1027,66,2439,283,2433,579,567],"class_list":["post-956","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-androgene","tag-antiandrogene","tag-bleichmittel","tag-cushing-syndrom","tag-cyproteronacetat","tag-cyproteronazetat","tag-dehydroepiandrosteron","tag-dhea","tag-eflornithin","tag-epilationsmittel","tag-estrogene-gestagene","tag-ferriman-gallwey-tafel","tag-flutamid","tag-haarwuchs","tag-hirsutismus","tag-hypertrichose","tag-orale-kontrazeptiva","tag-oestrogene-gestagene","tag-polyzystisches-ovar-syndrom","tag-prasteron","tag-sexualhormon-bindendes-globulin","tag-spironolacton","tag-testosteron"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=956"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/956\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}